ClinicalTrials.gg
Active, not recruitingNCT05310695NSACUpdated May 8, 2026

A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

An interventional study of NSAC - rapid and NSAC - ordinary in Musculoskeletal Disorder, Anxiety Disorders and Depression, sponsored by Nordlandssykehuset HF. Active, not recruiting at 5 sites in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Nordlandssykehuset HF · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,500
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The Norwegian Sickness Absence Clinic (NSAC) is a publicly funded specialist outpatient health service, which is uniquely available for the work force. The overall aim of the NSAC is prevention of sickness absence, promote return to work (RTW) among those on sickness absence and prevent long term disability benefit dependency. In addition to being a health service, the NSAC has a focus on work and functional recovery, including also non-health related factors. Patients can be referred by general practitioners for mental health problems and musculoskeletal problems. The NSAC has a lower threshold for severity than specialist health services generally, and in particular for mental health problems. The efficacy of this service is unknown.

The NSAC Efficacy Study is a randomized controlled multicentre trial which aims to assess the effect of the NSAC service. "Helse i Arbeid" is the Norwegian name for NSAC, and the Norwegian abbreviation is "HiA". The Norwegian study name is HIANOR.

The NSAC Efficacy Study involves five different NSACs across northern Norway, and will recruit 2500 patients, randomized to in equal proportions to three treatment arms:

  1. NSAC - rapid: treatment at the NSAC at- or within 4 weeks
  2. NSAC - ordinary: treatment at the NSAC after 10-14 weeks
  3. NSAC - active control: monodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval) The overall aim is to assess the effect of the NSAC service, with the hypothesis that the NSAC service is superior to what resembles treatment as usual (TAU) for outcomes such as return to work or improved health (waiting list control). Many of the diagnoses or problems for which patients are referred to the NSACs naturally improve regardless of health interventions, and - as of date - no research has been conducted to assess the efficacy of the service.
Read the detailed description

The Norwegian Sickness Absence Clinic (NSAC) is a publicly funded specialist outpatient health service, which is uniquely available for the work force. The overall aim of the NSAC is prevention of sickness absence, promote return to work (RTW) among those on sickness absence and prevent long term disability benefit dependency. In addition to being a health service, the NSAC has a focus on work and functional recovery, including also non-health related factors. Patients can be referred by general practitioners for mental health problems and musculoskeletal problems. The NSAC has a lower threshold for severity than specialist health services generally, and in particular for mental health problems. The efficacy of this service is unknown.

The NSAC Efficacy Study is part of a broader project, the Norwegian Sickness Absence Clinic Study (NSACS). The NSACS currently has two sources of funding: Northern Norway Regional Health Authority and The Norwegian Labour and Welfare Administration and involves two RCTs: NSAC Efficacy and NSAC Nudge and fifteen work packages concerning health economics, scalability, implementation, profiling of patient groups, and non-RCT related research questions to improve understanding of the patient group and their challenges. To do this the project will use patient survey data, clinician-reported procedures, opinions and outcomes, linked to registry data for work benefits and health service use. The randomized controlled trial NSAC Efficacy is the subject of this trial registration.

The NSAC Efficacy Study is a naturalistic randomized controlled multicentre trial, carried out in northern Norway and involving five NSACs. The study invites 2500 patients, randomized to either of three treatment arms:

  1. NSAC rapid: treatment at the NSAC at- or within 4 weeks
  2. NSAC ordinary: treatment at the NSAC after 10-14 weeks
  3. NSAC - active control: monodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval)

The NSACs are staffed by teams of medical doctors specializing in physical medicine and rehabilitation, psychologists, physiotherapists, and employment counsellors with experience from case management in the Norwegian Labor and Welfare Administration (NAV).

All patients are asked to complete an electronic survey about their mental health and musculoskeletal pain, work conditions, motivation for work and barriers for return to work (RTW). The control group only completes the survey on health, and only on either mental health or musculoskeletal pain, according to referral diagnosis.

The survey tool manages the randomization algorithm.

The NSAC is a relatively new clinical service, available for the labour force, and publicly funded with the intention to reduce sickness absence and prevent retirement from the labour force and transitions to disability benefits. The NSAC clinic welcomes patients with the most common diagnoses for sickness absence and is supposed to have a low threshold.

There is no single alternative clinical service for similar patients outside the labour force, thus no single treatment as usual (TAU) alternative. Service availability will depend on diagnosis and severity:

  • The majority of patients eligible for treatment in the NSAC referred with mental disorders would not be eligible for treatment in specialist psychiatric services as conditions in most cases would be too mild. The most common treatment alternative would be treatment at the general practitioners.
  • For patients referred for musculoskeletal problems, some may be eligible for consultations and treatment at physical medicine and rehabilitation outpatient clinics. For those not eligible, the general practitioner is the most common alternative, and other options such as private physiotherapists. Eligibility criteria may vary between catchment areas.
  • All alternatives to the NSAC would be without employment counsellors, little cross disciplinary assessment, and little to no focus on work and functional rehabilitation.

The active control group aims to be comparable to TAU, and differs from the NSAC in the following respects:

  1. Patients receive a monodisciplinary examination from either a doctor, physiotherapist of psychologist at the NSAC. The focus of the examination is on health-related factors. The patients will not receive further follow-up at the clinic beyond the first examination. Upon indication, the patient is referred to other treatment or examination outside of the NSAC.
  2. Employment counsellors are not involved in patient consultations or in discussions about patients.
  3. Patients in the active control group will not be posed questions concerning work, motivation for work or barriers for return to work. Patients will during registration in Tivian be classified as having predominantly either musculoskeletal- or common mental disorders, and this will dictate the type of questions posed: musculoskeletal patients will be asked questions on musculoskeletal factors but not psychological factors, while patients will common mental disorders will be asked questions about psychological factors but not musculoskeletal issues. For patients being examined by a psychologist, if issues concerning musculoskeletal health arise, the patient is asked to discuss these with his/her GP. If issues concerning mental health arise which requires competence beyond what the physiotherapist possesses, the physiotherapist may confer with the medical doctor at NSAC.
  4. The clinician is not to take initiative to discussing work-related factors with the patient, and as far as possible avoid these becoming central topics of the consultation. If the patient on his/her own initiative brings up such topics, the clinician is not restricted from addressing them.
  5. Employment counsellors are not part of patient discussions prior to examination.
  6. Meetings or discussions about patients are kept within profession; i.e. a physiotherapist is allowed to discuss his/her patient with other physiotherapists if need be.

The data necessary to answer the research questions are gathered from national registries via personal identifier, registry data on population level, questionnaires filled out by the patient (data on health and working conditions) and questionnaires filled out by the clinician (data on number of treatments, diagnosis, professions involved, and types of treatment provided).

The patient questionnaire covers 9 themes, split in two sections. Section 1 covers health, and includes musculoskeletal problems, mental health, and other health related issues (such as alcohol consumption, medication, and physical activity). Section 2 includes working conditions (including inter alia questions on social support, work/family conflict and bullying), barriers for RTW, labour market affiliation, other personal aspects (such as demography and motivation for work), questionnaires for health economic evaluation (such as the EQ-5D) and expectations for treatment.

By and large the questionnaire consists of test batteries which have been validated for specific topics. To reduce the number of questions posed to each patient, the baseline questionnaire will employ index questions which have proven psychometric properties in terms of factor loading or similar, meaning that if a problem on a specific topic such as neck pain is not indicated, the patient will not be presented with the Neck Disability Index questionnaire. The patient questionnaires will be filled out electronically at before first treatment and at 6- and 12 months after first treatment. In addition, before treatments, patients will be given shorter versions of the same questionnaire to be filled out at the clinic. These shorter questionnaires will consist of questions to which the patient at baseline indicated a high score, and thus includes more relevant information to the clinician.

In the NSAC Efficacy Study, receiving treatment at NSACs presupposes consent to participate in research, as the effect of the treatment is as of date unknown. Hence, receiving treatment at the NSAC is not necessarily superior to other available health services. Other available health services that may be utilized by patients serving in the control groups include mono-disciplinary treatment by physiotherapists, psychologists, general practitioners, gyms, electronically delivered self-help tools etc. All patients referred to NSACs will be offered treatment, but patients that decline to participate in research are provided an examination in line with randomization arm #3.

02

Conditions studied

  • Musculoskeletal Disorder
  • Anxiety Disorders
  • Depression
  • Fatigue
  • Pain
  • Occupational Exposure
  • Work Related Stress
  • Workplace Bullying
  • Employment
  • Sickness Absence
  • Return to Work

Keywords

  • Return to work
  • Sickness absence
  • Nudge
  • Barriers for return to work
  • Motivation for work
  • Demand and control
  • Work/family conflict
  • Bullying
03

In context

Musculoskeletal Diseases

753 studies on the registry are indexed under Musculoskeletal Diseases; 164 are open to participants now.

This study's planned enrollment of 2,500 is above the median of 76 across 519 interventional studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

Nordlandssykehuset HF is the lead sponsor of 21 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

* The patient must be considered eligible for treatment at the NSAC by the admission team at the NSAC.

Exclusion criteria

Exclusion Criteria:

  • Patients considered too healthy for treatment at the NSAC, i.e. not within target group
  • Patients considered too sick for treatment at the NSAC, i.e. not within target group
  • Patients that do not have a diagnosis that is relevant for treatment at the NSAC, i.e. not within target group
  • Patients otherwise considered not within target group for the measure
  • Patients which were included in the NSAC Nudge trial (clinicaltrials identifier: NCT05006976) may not be recruited within the first year of follow-up of that trial
  • Patients which are secondary referred from other departments/clinics within the hospital
  • Non-Norwegian or non-English speaking patients
  • Patients which could not be reached by the research coordinator at the outpatient clinic for information about the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
2,500 participants (estimated)

Study arms

  • Active comparator
    NSAC rapid: treatment at the NSAC at- or within 4 weeks

    NSAC service delivered according to ordinary procedures, 4 weeks after referral.

    Other: NSAC - rapid

  • Active comparator
    NSAC ordinary: treatment at the NSAC after 10-14 weeks

    NSAC service delivered according to ordinary procedures, 10-14 weeks after referral, by and large equivalent to current waiting time

    Other: NSAC - ordinary

  • Active comparator
    NSAC - active control

    Monodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval)

    Other: NSAC - active control

Interventions

  • OtherNSAC - rapid

    NSAC is an outpatient service delivered under the auspices of the specialist health care sector to patients currently on sick leave or at risk for long-term sickness absence. The service is staffed by medical doctors specialising in muskuloskeletal health, physiotherapists, psychologists and welfare sector counsellors, and aims to provide patients with a multi-diciplinary clarification or treatment of problems with the intent of improved function and return to work. Clinicians are provided survey information on the patients potential health problems, motivation for work, barriers for return to work and work environment prior to consultation. In this intervention arm, patients are offered treatment within 4 weeks of referral.

  • OtherNSAC - ordinary

    NSAC is an outpatient service delivered under the auspices of the specialist health care sector to patients currently on sick leave or at risk for long-term sickness absence. The service is staffed by medical doctors specialising in muskuloskeletal health, physiotherapists, psychologists and welfare sector counsellors, and aims to provide patients with a multi-diciplinary clarification or treatment of problems with the intent of improved function and return to work. Clinicians are provided survey information on the patients potential health problems, motivation for work, barriers for return to work and work environment prior to consultation. In this intervention arm, patients are offered treatment at 10-14 weeks after referral.

  • OtherNSAC - active control

    The active control intervention is provided by the NSAC personnel, but patients are offered a single monodisciplinary examination close to the end of the diagnosis-specific deadline suggested in guidelines, which will vary between 8-26 weeks. Employment counsellors may not be involved in consultations, other cross-disciplinary consultations are restricted, and work-related factors are not to be focused on during examination. Clinicians are provided survey information only on the patient's potential health problems prior to consultation. Patients are provided a health-focused examination, with the aim of symptom-relief.

06

What researchers measure

Primary outcomes

  1. Functional recovery: employment

    Employment during first 365 days post baseline survey, based on registry data and self-report.

    Time frame: 12 months post baseline survey

  2. Functional recovery: sickness absence

    Sickness absence during first 365 days post baseline survey, based on registry data and self-report.

    Time frame: 12 months post baseline survey

  3. Functional recovery: application for rehabilitation benefits

    Application for rehabilitation benefits during first 365 days post baseline survey, based on registry data and self-report.

    Time frame: 12 months post baseline survey

  4. Functional recovery: employment long term

    Employment during 5-and 10-year period post baseline survey, all based on registry data.

    Time frame: 5 and 10 years post baseline survey

  5. Functional recovery: sickness absence long term

    Sickness absence during 5-and 10-year period post baseline survey, all based on registry data.

    Time frame: 5 and 10 years post baseline survey

  6. Functional recovery: rehabilitation benefits long term

    Rehabilitation benefits during 5-and 10-year period post baseline survey, all based on registry data.

    Time frame: 5 and 10 years post baseline survey

  7. Functional recovery: disability benefits long term

    Disability benefits during 5-and 10-year period post baseline survey, all based on registry data.

    Time frame: 5 and 10 years post baseline survey

Secondary outcomes

  1. Mental health

    Changes in self-reported mental health between baseline survey and 6- and 12 months post baseline survey, measured using the Hopkins Symptoms Checklist - 10 (HSCL-10).

    Time frame: 12 months post baseline survey

  2. Anxiety

    Changes in self-reported anxiety between baseline survey and 6- and 12 months post baseline survey, measured using the Beck Anxiety Inventory (BAI). The instrument is provided to patients upon indication, defined as a HSCL-10 score \> 1.4

    Time frame: 12 months post baseline survey

  3. Depressive symptoms

    Changes in self-reported depression between baseline survey and 6- and 12 months post baseline survey, measured using the Beck Depression Inventory (BDI). The instrument is provided to patients upon indication, defined as a HSCL-10 score \> 1.4

    Time frame: 12 months post baseline survey

  4. Sleep

    Changes in self-reported sleep between baseline survey and 6- and 12 months post baseline survey, measured using 3 questions commonly used to diagnose sleeping disorder according to the DSM-IV criteria for insomnia.

    Time frame: 12 months post baseline survey

  5. Health Anxiety

    Changes in self-reported health anxiety between baseline survey and 6- and 12 months post baseline survey, measured using the Whitely Index. All patients are asked the first question in the test battery, and the entire instrument is provided to patients with a score of \>3 on this question

    Time frame: 12 months post baseline survey

  6. Subjective health complaints

    Changes in subjective healthbetween baseline survey and 6- and 12 months post baseline survey, measured using a modified version of the Ursin Health Inventory.

    Time frame: 12 months post baseline survey

  7. Back pain

    Changes in self-reported back pain between baseline survey and 6- and 12 months post baseline survey, measured using the Oswestry Disability Index (ODI). All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on localization of pain. In case of back pain, patients are provided the ODI.

    Time frame: 12 months post baseline survey

  8. Neck pain

    Changes in self-reported neck pain between baseline survey and 6- and 12 months post baseline survey, measured using the Neck Disability Index (NDI). All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on localization of pain. In case of neck pain, patients are provided the NDI.

    Time frame: 12 months post baseline survey

  9. Pain intensity

    Changes in self-reported pain intensity between baseline survey and 6- and 12 months post baseline survey, measured using a visual analogue scale scored between 0 and 10. All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on pain intensity during rest and activity.

    Time frame: 12 months post baseline survey

  10. Fear avoidance

    Changes in self-reported fear avoidance between baseline survey and 6- and 12 months post baseline survey, measured using the Fear Avoidance Beliefs Questionnaire (FABQ). All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided the FABQ.

    Time frame: 12 months post baseline survey

  11. Physical activity

    Changes in self-reported level of physical between baseline survey and 6- and 12 months post baseline survey, measured using the Saltin-Grimby Physical Activity Level Scale (SGPALS).

    Time frame: 12 months post baseline survey

  12. Fatigue

    Changes in self-reported fatigue between baseline survey and 6- and 12 months post baseline survey, measured using the Fatigue Assessment Scale. All patients are asked the first question in the test battery, and the entire instrument is provided to patients with a score of ≥ 3 on this question

    Time frame: 12 months post baseline survey

  13. Pain localization

    Changes in self-reported localization of pain between baseline survey and 6- and 12 months post baseline survey. All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on localization of pain.

    Time frame: 12 months post baseline survey

  14. Cause of pain

    Changes in self-reported cause of pain between baseline survey and 6- and 12 months post baseline survey. All patients are asked whether they suffer from musculoskeletal pain, and if present, they are provided questions on the believed cause of pain.

    Time frame: 12 months post baseline survey

  15. Self-reported diagnosis

    Changes in self-reported diagnoses between baseline survey and 6- and 12 months post baseline survey. The respondent is asked whether he/she thinks they have Covid-19 sequelae, myalgic encephalomyelitis/chronic fatigue syndrome, whiplash, fibromyalgia, hypermobility, irritable bowel syndrome or food intolerance, or whether they have been diagnosed with either of these by health personnel.

    Time frame: 12 months post baseline survey

Other outcomes

  1. Preventive effect of sickness absence

    Changes in self-reported beliefs about the potential preventive effect of short-term sickness absence on long term sickness absencebetween baseline survey and 6- and 12 months post baseline survey. The respondent is asked whether he/she agrees to 5 different statements on this topic, using a 5-point likert scale.

    Time frame: 12 months post baseline survey

  2. Health care utilization

    Based on registry data from publicly funded specialist health services and primary care, we will examine if there is any effect of the intervention on use of other health services during follow-up.

    Time frame: At 12 and 60 months post first appointment at NSAC

  3. Health economic evaluation: self report EQ-5D

    Health economic evaluation is measured using the EQ-5D instrument, issued to patients prior to first treatment and 6- and 12 months post baseline survey to assess change.

    Time frame: 12 months post baseline survey

  4. Health economic evaluation: self report ReQol

    Health economic evaluation is measured using the ReQol instrument, issued to patients prior to first treatment and 6- and 12 months post baseline survey to assess change.

    Time frame: 12 months post baseline survey

  5. Health economic evaluation: labour costs

    Health economic evaluation also involves data on number of professions seeing the patient and number of working hours spent on the patient by each profession seeing the patient during the treatment period, recorded in questionnaires filled out by the clinicians after each consultation. This enables calculation of costs in terms of manpower and staff.

    Time frame: Time Frame: 12 months post baseline survey

  6. Expectations to- and evaluation of treatment

    Using open-ended questions, patients are asked about their expectations towards treatment prior to first treatment, and about their evaluation of treatment 6- and 12 months after baseline survey. These two will be compared.

    Time frame: 12 months post baseline survey

  7. Barriers for return to work

    Changes in self-reported barriers for return to work between prior to first treatment and 6- and 12 months post baseline survey. The questionnaire includes 26 items concerning barriers for return to work.

    Time frame: 12 months post baseline survey

  8. Motivation for work

    Changes in self-reported motivation for work between baseline survey and 6- and 12 months post baseline survey. The questionnaire consists of a number of questions concerning motivation.

    Time frame: 12 months post baseline survey

  9. Effort/reward imbalance

    Changes in self-reported effort/reward imbalance (ERI) between baseline survey and 6- and 12 months post baseline survey. ERI is measured using the 3 items with the highest factor loading in the Siegrist Effort/Reward Imbalance Questionnaire (short version). A high score on either of the three items triggers the rest of the questionnaire.

    Time frame: 12 months post baseline survey

  10. Workplace bullying

    Changes in self-reported workplace bullying between baseline survey and 6- and 12 months post baseline survey. Workplace bullying is measured using the Short Negative Acts Questionnaire (SNAQ).

    Time frame: 12 months post baseline survey

  11. Economic situation

    Changes in self-reported economic situation between baseline survey and 6- and 12 months post baseline survey. The questionnaire includes 2 items concerning economic problems and concerns about economic problems.

    Time frame: 12 months post baseline survey

  12. Procedural justice

    Changes in self-reported procedural justice between baseline survey and 6- and 12 months post baseline survey. It is measured by 3 items concerning workplace decisions.

    Time frame: 12 months post baseline survey

  13. Relational justice

    Changes in self-reported relational justice between baseline survey and 6- and 12 months post baseline survey. Relational justice is measured by 4 items concerning the general behaviour of the respondent's supervisor.

    Time frame: 12 months post baseline survey

  14. Job phobia

    Changes in self-reported job phobias between baseline survey and 6- and 12 months post baseline survey. Job phobia is measured by 12 items concerning the respondent's avoidance of the workplace or work-related anxiety.

    Time frame: 12 months post baseline survey

  15. Ergonomic work environment

    Changes in self-reported ergonomic work environment between baseline survey and 6- and 12 months post baseline survey. Ergonomic work environment is measured by 11 items concerning the respondent's physical tasks at work.

    Time frame: 12 months post baseline survey

  16. Organisational change

    Changes in self-reported organisational change between baseline survey and 6- and 12 months post baseline survey. Organisational change is measured using the 3 items covering changes in management, colleagues and tasks.

    Time frame: 12 months post baseline survey

  17. Work/family conflict

    Changes in self-reported work/family conflict between baseline survey and 6- and 12 months post baseline survey. Work/family conflict is measured using the 4 items with the highest factor loading in the Home-Work Interference Scale.

    Time frame: 12 months post baseline survey

  18. Demand and control

    Changes in self-reported demand and control between baseline survey and 6- and 12 months post baseline survey. Demand and control is measured using three questions from the instrument developed by Karasek/Theorell. A high score on either of the three items triggers the rest of the questionnaire.

    Time frame: 12 months post baseline survey

07

Study locations

5 sites
  • Helse I Arbeid Nordlandssykehuset
    Bodø, Nordland 8092, Norway
  • Helse I Arbeid Helgelandssykehuset
    Sandnessjøen, Nordland 8800, Norway
  • Helsepartner Rehabilitering Alta
    Alta, Troms Og Finnmark 9510, Norway
  • Helse I Arbeid Finnmarkssykehuset
    Kirkenes, Troms Og Finnmark 9915, Norway
  • Helse I Arbeid Universitetssykehuset Nord-Norge
    Tromsø, Troms Og Finnmark 9019, Norway
08

References and documents

Publications

  • Aars NAP, Bardal I, Terjesen C, Hansen BO, Jerven A, Kaspersen KI, Lyngedal O, Huttepohl F, Johnsen I, Uglebakken TO, Brinchmann B, Mykletun A. Multicentre randomised controlled trial of the Norwegian health in work service for patients with common mental disorders or musculoskeletal disorders: the Norwegian Sickness Absence Clinic (NSAC) Efficacy Study. BMJ Open. 2026 May 28;16(5):e109083. doi: 10.1136/bmjopen-2025-109083. PubMed 42209002 ↗

Individual participant data

Plan to share: No — There are no plans to share individual patient data with other researchers. At the stage of analyses, associated researchers will be provided with an anonymized data set including all relevant data to answer the research questions.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2023 (actual). Primary completion is estimated for Oct 2026, 45 months after the start.

Of 251 non-industry interventional studies with no phase under Musculoskeletal Diseases, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 45 months is above that.

Counting every sponsor, half of 266 studies reached it within 16 months; a quarter within 6 and three quarters within 36.

Musculoskeletal Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2022
First posted
Apr 5, 2022
StartActual
Jan 16, 2023
Primary completionEst.
Oct 2026
CompletionEst.
Oct 2034
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05310695
Lead sponsor
Nordlandssykehuset HF
Collaborators
University Hospital of North Norway, Helgeland Hospital Trust, Finnmarkssykehuset HF (Kirkenes, Norway), UiT The Arctic University of Norway
Responsible party
Sponsor
First posted
Apr 5, 2022
Start date
Jan 16, 2023
Primary completion
Oct 2026 (estimated)
Completion
Oct 2034 (estimated)
Last update
May 8, 2026

Study contacts

Arnstein Mykletun, PhD
principal investigator · UiT The Arctic University of Norway

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion